-
February 15, 2022 The Psychedelic CEO Round Table | feat. MindMed, Cybin, Field Trip and the Psychedelic InvestorThe Psychedelic CEO Round Table | feat. MindMed, Cybin, Field Trip and the Psychedelic Investor...
-
February 11, 2022 Psychedelic Business Spotlight – February 11This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads...
-
February 11, 2022 Curing Alcoholism with Ketamine Therapy? | Interview with Psychedelic Scientist Dr. Ben Sessa -AwaknIn today's episode of The Psychedelic Investor, James Hallifax interviews Dr. Ben Sessa of Awakn...
-
February 10, 2022 Cathie Wood’s ARK Genomic Revolution ETF Buys Psychedelic StockOur resident Psychedelic Investor explains why this is an important moment for the psychedelics sector.
-
February 10, 2022 Cathie Wood and ARK Invest Buy a Psychedelic Stock!!! | $ARKG | Initial Reaction 🍄🍾GUYS. IT HAPPENED. Cathie Wood and ARK Invest have invested in a Psychedelic Stock! Specifically,...
-
February 9, 2022 DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics IndustryProblematic patents have serious implications for the entire psychedelics industry.
-
February 8, 2022 The Thesis for Investing in Psychedelic StocksOur resident Psychedelic Investor makes the case why the psychedelic sector may yield big returns.
-
February 4, 2022 4 Tips for Investing in Psychedelic Stocks During a Market DownturnFriendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a...
-
February 4, 2022 Psychedelic Business Spotlight – February 4Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news,...
-
January 31, 2022 Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for PsychedelicsThe partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader...
